| The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections J Machhi, J Herskovitz, AM Senan, D Dutta, B Nath, MD Oleynikov, ... Journal of neuroimmune pharmacology 15, 359-386, 2020 | 734 | 2020 |
| Diagnostics for SARS-CoV-2 infections BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ... Nature materials 20 (5), 593-605, 2021 | 715 | 2021 |
| Nanocarrier vaccines for SARS-CoV-2 J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Advanced Drug Delivery Reviews 171, 215-239, 2021 | 92 | 2021 |
| A role for extracellular vesicles in SARS-CoV-2 therapeutics and prevention J Machhi, F Shahjin, S Das, M Patel, MM Abdelmoaty, JD Cohen, ... Journal of Neuroimmune Pharmacology 16, 270-288, 2021 | 43 | 2021 |
| Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking IZ Mukadam, J Machhi, J Herskovitz, M Hasan, MD Oleynikov, ... Biomaterials 231, 119669, 2020 | 21 | 2020 |
| Pharmacotherapeutics of SARS-CoV-2 infections BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ... Journal of Neuroimmune Pharmacology 16, 12-37, 2021 | 10 | 2021 |
